Rubicon Organics Announces Health Canada Cultivation License For Cascadia (Hope, BC) Facility

Executive Summary

• Rubicon Organics received a Health Canada license for its Cascadia facility, adding 4,500 kg of annual production capacity (≈40% increase).
• Total premium cannabis capacity now stands at 15,500 kg per year, with operations already underway and first revenue expected in H1 2026.
• The company renamed its existing Delta and Hope facilities to Pacifica and Cascadia, respectively, reflecting a broader domestic and international growth focus.

Key Details

• License Approval: Health Canada granted cultivation, processing, and storage licences for the 47,500‑sq‑ft Cascadia facility in Hope, BC.
• Capacity Impact: Additional 4,500 kg of premium cannabis production capacity – a 40% boost to existing capacity, raising total annual capacity to 15,500 kg.
• Timeline: Facility operations are active; first revenue from Cascadia anticipated in the first half of 2026.
• Facility Naming: Existing Delta facility renamed “Pacifica”; Hope facility renamed “Cascadia.”
• Strategic Rationale (CEO Quote): “This additional 40% capacity will allow Rubicon to meet currently unmet demand for our award‑winning premium products in Canada and in additional markets…provides an indoor cultivation environment …to address international market opportunities.” – Margaret Brodie, CEO.

Notable Quotes

• “The receipt of this license is a significant step in the transformation of Rubicon Organics. This additional 40% capacity will allow Rubicon to meet currently unmet demand for our award‑winning premium products in Canada and in additional markets.” – Margaret Brodie, CEO.